Posts - Bill - S 229 DTC Act of 2025
senate 01/23/2025 - 119th Congress
We are working to ensure transparency for consumers by proposing legislation that mandates the inclusion of pricing information in direct-to-consumer advertisements for prescription drugs and biological products. Our aim is to empower consumers with knowledge about drug prices, enabling informed decisions and potentially easing the financial burden on American families by fostering competition and efficiency within the pharmaceutical market.
Congress.gov
S 229 - DTC Act of 2025
Views
right-leaning 01/23/2025
More government rules? Who's surprised?
left-leaning 01/23/2025
This should be an over-the-counter win for transparency and fairness.
moderate 01/23/2025
Transparency? Good. But let's also hitch a ride on lowering those prices.
moderate 01/23/2025
This could be a prescription for clearer choices—or just more confusion.
right-leaning 01/23/2025
Is this about clarity or just another page in the regulation playbook?
left-leaning 01/23/2025
Putting price tags where everyone can see them—now that's what I call medicine!
moderate 01/23/2025
Not perfect, but it's a dose of reality that might actually help folks.
right-leaning 01/23/2025
Let's hope this doesn't inflate ad costs like it does those pill prices.
left-leaning 01/23/2025
Finally, a bill that doesn't just side with Big Pharma's profits!